bcl-2 inhibitor abbv-453
Generic: Bcl-2 Inhibitor ABBV-453
bcl-2 inhibitor abbv-453: 1 clinical trial tracked.
bcl-2 inhibitor abbv-453 evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about bcl-2 inhibitor abbv-453, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence1 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trial Registry Records (1)
A Phase 1 Study Evaluating Safety, Pharmacokinetics, and Efficacy of ABBV-453 in Adult Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Primary endpoint: Percentage of Participants With Adverse Events (AEs)
Interventionalopen4 enrolledStarted 2025-01Completion 2027-0721 sites · Australia, Germany, Israel, Italy…AbbVie